Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population
Shaoyan Lin(Nanjing Agricultural University), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yiqun Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiuwen Guan(Chinese Academy of Medical Sciences & Peking Union Medical College), Zijing Wang(Qingdao University), Yimeng Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongnan Mo(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 12
Related Papers
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
|Signal Transduction and Targeted Therapy|2019|406
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
|British Journal of Cancer|2018|156